You just read:

Syndax Announces Clinical Data from its Entinostat Immuno-oncology Program Selected for Two Oral Presentations at the American Association for Cancer Research Annual Meeting 2019

News provided by

Syndax Pharmaceuticals, Inc.

Feb 27, 2019, 16:47 ET